ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2681

Activated SLE-T Cells Enhance the Interferon-Alpha Production By Plasmacytoid Dendritic Cells Stimulated By RNA-IC

Dag Leonard1, Maija-Leena Eloranta1, Niklas Hagberg1, Olof Berggren1, Karolina Tandre1, Gunnar Alm2 and Lars Rönnblom1, 1Department of Medical Sciences, SciLife Lab, Rheumatology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden, 2Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden, Uppsala, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: SLE, T cells and interferons

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants

Session Type: Abstract Submissions (ACR)

Background/Purpose

A prominent interferon-α (IFNα) signature is seen in several autoimmune diseases including systemic lupus erythematosus (SLE). Plasmacytoid dendritic cells (pDCs) are the main IFNα producing cells and produce large amounts of IFNα in response to immune complexes containing nucleic acids (ICs). Produced IFNα activates the immune system in a number of ways, including polarization of naïve T helper cells to Th1 cells, expansion and activation of cytotoxic CD8+ T cells and enhanced B-cell differentiation and antibody production. Thus, once pDCs are activated they strongly promote the adaptive immune response.  However, much less is known about the effects on pDCs by different adaptive immune cells. Therefore, we asked if T cells can promote the IFNα production by pDCs stimulated by RNA containing ICs.

Methods

Human T cells were activated by anti-CD3/CD28 antibodies. T cells or supernatant from T cell cultures were co-cultured with pDCs stimulated with ICs containing U1 snRNP particles and SLE-IgG (RNA-IC). Cells were analyzed by flow cytometry and cytokines in supernatants were depleted or blocked by monoclonal antibodies. Supernatants were analyzed for IFNα and other cytokines.

Results

Activated T cells or supernatants from activated T cells increased the IFNα production by pDCs stimulated by RNA-IC >20-fold. The frequency of pDCs expressing intracellular IFNα increased when co-cultured with activated CD4+ T cells (5.8%) or CD8+ T cells (6.8%) compared to pDC cultured alone (0.2%). When cytokines were added to the RNA-IC stimulated pDCs at the same concentration as in the supernatant from activated T cells, both GM-CSF and IL-3 demonstrated a strong stimulatory effect on the IFNα response. The combination of both cytokines increased the IFNα production as much as supernatants from activated T cell. The stimulatory effect of supernatants was significantly reduced after depletion of GM-CSF (81%), blocking of GM-CSF (92%) or its receptor subunits CD131 and CD116 (55-81%), (all p<0.05).  Blocking of IL-3 or its receptor subunit CD123 also reduced the stimulatory effect of the supernatant (31% and 32%, respectively). Supernatant from activated T cells increased the frequency of CD80 and CD86 expressing pDC from 6% to 35% (p<0.05) and 10% to 26% (p<0.01), respectively.  Furthermore, when RNA-IC was added to pDCs cultured with GM-CSF and IL-3, an increased frequency of CD80 and CD86 (p<0.05) expressing pDCs were observed. Activated SLE T cells enhanced the IFNα production to the same extent as T cells from healthy controls. Detectable levels of serum-GM-CSF was found in 31% of SLE patients (n=51), who had a more active or severe disease.

Conclusion

Activated T cells enhance the IFNα production by RNA-IC stimulated pDCs via GM-CSF and IL-3, which induce maturation of the pDCs. Previous findings of activated T cells in patients with SLE and our observation of a subset of SLE patients expressing increased levels of serum-GM-CSF suggests that T cells contribute to the activated type I interferon system in SLE. Thus, a bidirectional crosstalk between the type I IFN system and the adaptive immune system seems to exist in SLE.

 


Disclosure:

D. Leonard,
None;

M. L. Eloranta,
None;

N. Hagberg,
None;

O. Berggren,
None;

K. Tandre,
None;

G. Alm,
None;

L. Rönnblom,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activated-sle-t-cells-enhance-the-interferon-alpha-production-by-plasmacytoid-dendritic-cells-stimulated-by-rna-ic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology